Cargando…

Tuberculosis in migrants – screening, surveillance and ethics

Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Scandurra, Gabriella, Degeling, Chris, Douglas, Paul, Dobler, Claudia C., Marais, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473829/
https://www.ncbi.nlm.nih.gov/pubmed/32923311
http://dx.doi.org/10.1186/s41479-020-00072-5
_version_ 1783579243390697472
author Scandurra, Gabriella
Degeling, Chris
Douglas, Paul
Dobler, Claudia C.
Marais, Ben
author_facet Scandurra, Gabriella
Degeling, Chris
Douglas, Paul
Dobler, Claudia C.
Marais, Ben
author_sort Scandurra, Gabriella
collection PubMed
description Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO’s) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination.
format Online
Article
Text
id pubmed-7473829
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74738292020-09-08 Tuberculosis in migrants – screening, surveillance and ethics Scandurra, Gabriella Degeling, Chris Douglas, Paul Dobler, Claudia C. Marais, Ben Pneumonia (Nathan) Review Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO’s) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination. BioMed Central 2020-09-05 /pmc/articles/PMC7473829/ /pubmed/32923311 http://dx.doi.org/10.1186/s41479-020-00072-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Scandurra, Gabriella
Degeling, Chris
Douglas, Paul
Dobler, Claudia C.
Marais, Ben
Tuberculosis in migrants – screening, surveillance and ethics
title Tuberculosis in migrants – screening, surveillance and ethics
title_full Tuberculosis in migrants – screening, surveillance and ethics
title_fullStr Tuberculosis in migrants – screening, surveillance and ethics
title_full_unstemmed Tuberculosis in migrants – screening, surveillance and ethics
title_short Tuberculosis in migrants – screening, surveillance and ethics
title_sort tuberculosis in migrants – screening, surveillance and ethics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473829/
https://www.ncbi.nlm.nih.gov/pubmed/32923311
http://dx.doi.org/10.1186/s41479-020-00072-5
work_keys_str_mv AT scandurragabriella tuberculosisinmigrantsscreeningsurveillanceandethics
AT degelingchris tuberculosisinmigrantsscreeningsurveillanceandethics
AT douglaspaul tuberculosisinmigrantsscreeningsurveillanceandethics
AT doblerclaudiac tuberculosisinmigrantsscreeningsurveillanceandethics
AT maraisben tuberculosisinmigrantsscreeningsurveillanceandethics